Filter
112
Filtered Results: 112
Text search:
selective
serotonin
reuptake
inhibitors
Featured
Recommendations
22
New Publications
19
Language
Document type
No document type
81
Guidelines
12
Manuals
11
Studies & Reports
5
Training Material
3
Countries / Regions
India
9
Global
3
Zambia
2
Jamaica
2
Liberia
1
Uganda
1
Nepal
1
South Sudan
1
Syria
1
Kenya
1
Indonesia
1
South Africa
1
Bangladesh
1
Singapore
1
Ukraine
1
Libya
1
Myanmar / Burma
1
Asia
1
Canada
1
Authors & Publishers
Publication Years
Category
Countries
20
Clinical Guidelines
14
Public Health
10
Women & Child Health
4
Capacity Building
1
Key Resources
1
Toolboxes
Mental Health
68
Pharmacy
6
TB
4
HIV
3
COVID-19
2
Caregiver
2
NCDs
2
Natural Hazards
1
Refugee
1
mhGAP Training of Health-care Providers Training manual and Supporting material.
Overview
Learning objectives
• Promote respect and dignity for children and adolescents with mental and behavioural
disorders.
• Know common presentations of children and adolescents with mental and behavioural
disorders.
• Know assessment principles of child and adolescents with mental ...
This guide was developed by AACAP to give reliable information about medication
used to treat bipolar disorder in children and adolescents to parents whose children
have been diagnosed with the illness.
Q9: Antidepressant medicines in individuals with a depressive episode in bipolar disorder1Q9: In individuals presenting with a depressive episode in bipolar disorder, are antidepressant medicines effective and safe?
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttrau...
AACAP OFFICIAL ACTION | This Practice Parameter identifies best approaches to the assessment and management of children and adolescents across all phases of a disaster. Delivered within a disaster system of care, many interventions are appropriate for implementation in the weeks and months after a d...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Introduction
Chapter A.7
Mood disorders
Chapter E.1
2015 edition
Mood disorders
Chapter E.2
Anxiety disorders
Chapter F.1
2018 edition
Anxiety disorders
Chapter F.2
Anxiety disorders
Chapter F.3
Trastornos de ansiedad
Capítulo F.3
Editores: Laura Revert, Matías Irarrázaval & Andres Martin
Traducción: Régis Villegas, Paula Placencia, José Ángel Alda & Paula Cox
Troubles Anxieux
Chapitre F.3
Edition en français
Traduction : Alexis Revet
Sous la direction de : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Section I
Somatoform disorders
Child Psychiatry and Pediatrics
Chapter I.1
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output and the link between mental disorders and costly, po...
